Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Reexamination Certificate
2011-08-16
2011-08-16
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
Reexamination Certificate
active
07999011
ABSTRACT:
Provided is a method of treating a patient having a tissue that is subject to an ischemic event. The method is conducted by parenterally administering a formulation containing a halogenated volatile anesthetic in an amount effective to improve the tissue's resistance to or tolerance of the ischemic event. In preferred embodiment of the invention, the amount of the formulation administered to the patient is sub-anesthetic. The formulation can be administered prior to, concurrently with, or after the ischemic event. The method can be used, for example, for treatment of patients having myocardial or neuronal tissue that is subject to an ischemic event.
REFERENCES:
patent: 4073943 (1978-02-01), Wretlind et al.
patent: 5628930 (1997-05-01), Weers et al.
patent: 5635538 (1997-06-01), Weers et al.
patent: 5885984 (1999-03-01), MacLeod et al.
patent: 2350297 (2000-11-01), None
patent: WO 00/72820 (2000-12-01), None
patent: WO-02/07729 (2002-01-01), None
Saito et al. (Reduction of Infarct Volume by Halothane: Effect on Cerebral Blood Flow or Perifocal Spreading Depression-Like Depolarizations, Journal of Cerebral Blood Flow and Metabolism, 1997, vol. 17, pp. 857-864).
Canadian Anaesthetists' Society journal. Nov. 1978, vol. 25, No. 6, pp. 488-494.
Gallagher et al. Anesthesia & Analgesia, 1998, vol. 86, pp. 488-492.
Werner et al; Sevoflurane Improves Neurological Outcome After Incomplete Cerebral Ischaemia in Rats; Br J Anaesth.; Dec. 1995; pp. 756-760; 75(6).
Beirne et al; Effect of Halothane in Cortical Cell Cultures Exposed to N-methyl-D-aspartate; Neurochem Res. Jan. 1998; pp. 17-23; 23(1).
Grady et al; Correlation of Regional Cerebral Blood Flow with Ischemic Electroencephalographic Changes . . . ; Anesthiology; Apr. 1998; 88(4); pp. 892-897.
Soonthon-Brant et al; Fentanyl Does Not Increase Brain Injury after Focal Ischemia in Rats; Anesth Analg.; Jan. 1999; pp. 49-55; 88(1).
Patel et al; Isoflurane and Pentobarbital Reduce the Frequency of Transient Ischemic Depolarizations During Focal Ischemia in Rats; Anesth Analg.; Apr. 1998; pp. 773-780; 86(4).
Miura et al; Differential Effects of Anesthetic Agents on Outcome from Near Complete but Not Incomplete Global Ischemia in the Rat; Anesthesiology Aug. 1998; pp. 289-291; 89(2).
De Hert et al; Contraction-Relaxation Coupling and Impaired Left Ventricular Performance in Coronary Surgery Patients; Anesthiology Mar. 1999; pp. 748-757; 90(3).
De Hert et al; Length-Dependent Regulation of Left Ventricular Function in Coronary Surgery Patients; Anesthiology Aug. 1999; pp. 379-387; 91(2).
De Hert et al; The Effects of Beta-Adrenergic Stimulation on the Length-Dependent Regulation of Myocardial . . . ; Anesth Analg. Oct. 1999; pp. 835-842; 89(4).
Engelhard et al; Desflurane and Isoflurane Improve Neurological Outcome after Incomplete Cerebral Ischaemia in Rats; Br J Anaesth. Sep. 1999; pp. 415-421; 83(3).
Belhomme et al; Evidence for Preconditioning by Isoflurane in Coronary Artery Bypass Graft Surgery; Circulation Nov. 9, 1999; pp. II-340-II-344.
Wenker Oliver C; Review of Currently Used Inhalation Anesthetics : Part I; The Internet Journal of Anesthiology 1999; vol. 3(2).
Wenker Oliver C; Review of Currently Used Inhalation Anesthetics : Part II; The Internet Journal of Anesthiology 1999; vol. 3(3).
Kimbro et al; Isoflurane and Pentobarbital Reduce AMPA Toxicity In Vivo in the Rat Cerebral Cortex; Anesthesiology Mar. 2000; pp. 806-812; 92(3).
Kawaguchi et al; Isoflurane Delays but Does Not Prevent Cerebral Infarction in Rats Subjected to Focal Ischemia; Anesthesiology May 2000; pp. 1335-1342; 92(5).
Roscoe et al; Isoflurane, but Not Halothane, Induces Protection of Human Myocardium via Adenosine A1 Receptors . . . ; Anesthiology Jun. 2000; pp. 1692-1701; 92(6).
Toller et al; Sarcolemmal and Mitochondrial Adenosine Triphosphate-Dependent Potassium Channels; Anesthiology Jun. 2000; pp. 1731-1739; 92(6).
Nellgard et al; Anesthetic Effects on Cerebral Metabolic Rate Predict Histological Outcome From . . . ; Anesthiology Aug. 2000; pp. 431-436; 93(2).
Hans et al; Neuroprotection with Anaesthetic Agents; Current Opinion in Anaesthiology 2001; pp. 491-496; vol. 14.
Haroun-Bizri et al; Does Isoflurane Optimize Myocardial Protection During Cardiopulmonary Bypass? J Cardiothorac Vasc Anesth. Aug. 2001; pp. 418-421; 15(4).
Hanouz et al; Mechanisms of Desflurane-Induced Preconditioning in Isolated Human Right Atria in Vitro; Anesthiology Jul. 2002; pp. 33-41; 97(1).
De Hert et al; Sevoflurane but Not Propofol Preserves Myocardial Function in Coronary Surgery Patients; Anesthiology Jul. 2002; pp. 42-49; 97(1).
Warltier et al; Anesthetic Preconditioning; Serendipity and Science; Anesthiology Jul. 2002; pp. 1-3; 97(1).
Cuignet et al; A Second-Generation Blood Substitute (Perflubron Emulsion) Increases the Blood Solubility of Modern Volatile . . . ; Anesth Analg Aug. 2002; pp. 368-372.
Park KW; Cardiovascular Effects of Inhalational Anesthetics; Int. Anesthiol Clin; Winter 2002; pp. 1-14; 40(1).
De Hert et al; Effects of Propofol, Desflurane, and Sevoflurane on Recovery of Myocardial Function . . . ; Anesthiology Aug. 2003; pp. 314-323; 99(2).
Conzen et al; Sevoflurane Provides Greater Protection of the Myocardium Than Propofol in Patients Undergoing Off-Pump . . . ; Anesthiology Oct. 2003; pp. 826-833; 99(4).
Engelhard et al; The Effect of Sevoflurane and Propofol on Cerebral Neurotransmitter Concentrations During Cerebral Ischemia in Rats; Anesth Analg. Oct. 2003, pp. 1155-1161; 97(4).
Faithfull et al., “Protection against myocardial ischemia by prior hemodilution with fluorocarbon emulsions,”Br. J. Anaesth., 60:773-778 (1988).
Supplementary European Search Report for corresponding European application No. EP03774657, dated Feb. 28, 2008.
“Effect of halothane and sevoflurane on myocardial function and oxygen-derived free radicals during ischemia and reperfusion,” Chinese J. Pathophysiology, 15(4):313-314 (1999) (abstract).
International Search Report for PCT/US03/31826, dated Jul. 7, 2004.
Japanese Office Action for JP Application No. 2004-543499, dated Jun. 8, 2010.
Japanese Office Action for JP Application No. 2004-543499, dated Jun. 8, 2010. (English Translation).
Akazawa et al., Kyoketsushin ni oyobosu Sebofururen no eikyo (Effects of Sevoflurane on ischemic heart),Masui(Anesthesia), 42:S66 (Oct. 1993).
Akazawa et al., Kyoketsushin ni oyobosu Sebofururen no eikyo (Effects of Sevoflurane on ischemic heart),Masui(Anesthesia), 42:S66 (Oct. 1993). (English Translation).
Cryonics Issue #17, Meat, Dec. 1981. Selected contents: Cryonics. Downloaded from the Internet at: <http://www.alcor.org/cryonics/cryonics8112.txt>.
Imai et al., Kyunyumasuiyaku no kankyoketsu-saikanryushogai ni oyobosu eikyo (The effect of inhalation anesthetics on ischemia-reperfusion injury in liver),Masui(Anesthesia), 42: S71 (Oct. 1993).
Imai et al., Kyunyumasuiyaku no kankyoketsu-saikanryushogai ni oyobosu eikyo (The effect of inhalation anesthetics on ischemia-reperfusion injury in liver),Masui(Anesthesia), 42: S71 (Oct. 1993). (English Translation).
Kanaya et al., Isofururen no saikanryu shinkintaisha ni oyobosu eikyo (Effects of isoflurane anesthesia on myocardial metabolism in reperfused heart), Masui (Anesthesia), 42: S326 (Oct. 1993).
Kanaya et al., Isofururen no saikanryu shinkintaisha ni oyobosu eikyo (Effects of isoflurane anesthesia on myocardial metabolism in reperfused heart), Masui (Anesthesia), 42: S326 (Oct. 1993). (English Translation).
Kon et al., Isofururene kankyoketsu-saikanryushogai ni oyobosu eikyo (The effects of isoflurane on ischemia-reperfusion injury in liver), Masui (Anesthesia), 42:S261 (Oct. 1993).
Kon et al., Isofururene kankyoketsu-saikanryushogai ni oyobosu eikyo (The effects of isoflurane on ischemia-reperfusion injury in liver), Masui (Anesthesia), 42:S261 (Oct. 1993). (English Translation).
Toda et al., Sebofururen no kandomyaku kakuchosayo (Vasodilator effect of sevoflurane in coronary arteries),Masui(Anesthesia), 42:S339 (Oct. 1993).
Toda et al., Sebofururen no kandomyaku kakuchosayo (Vasodilator effect
Lessor Ralph A.
Pejaver Satish
Puri Navneet
Trillo Raul
Baxter International Inc.
Jean-Louis Samira
Marshall & Gerstein & Borun LLP
Padmanabhan Sreeni
LandOfFree
Method for cardioprotection and neuroprotection by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for cardioprotection and neuroprotection by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for cardioprotection and neuroprotection by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2788547